These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2659292)

  • 1. Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    Chemotherapy; 1989; 35 Suppl 1():72-6. PubMed ID: 2659292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.
    Barry AL; Thornsberry C; Jones RN; Gavan TL
    Rev Infect Dis; 1985; 7 Suppl 4():S594-604. PubMed ID: 3909316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
    Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftazidime, cefotaxime and gentamicin against 11,521 clinical isolates of bacteria.
    Steinbakk M; Midtvedt T; Lingaas E; Gardsjord G
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):337-46. PubMed ID: 3326398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
    Norris SM; Guenthner SH; Wenzel RP
    J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of clinical isolates to aztreonam].
    Asari S; Horikawa M; Tsukamoto H; Kouda K; Hayashi C; Miyai K
    Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.
    Heym B; Lacroix O; Péan Y; Gertner J; Nicolas MH; Jarlier V
    J Antimicrob Chemother; 1994 Apr; 33(4):729-35. PubMed ID: 8056691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
    Le Noc P; Croize J; Le Noc D
    Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidime.
    Bremner DA
    Pathology; 1987 Jul; 19(3):274-6. PubMed ID: 3124067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection.
    Webb G; Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Int J Clin Pharmacol Res; 1987; 7(3):203-5. PubMed ID: 3298085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of newer antibiotics against gram-negative bacilli.
    Knapp CC; Washington JA
    Cleve Clin J Med; 1989; 56(2):161-6. PubMed ID: 2731335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temocillin. In vitro antibacterial activity.
    Slocombe B; Cooper CE; Griffin KE; White AR
    Drugs; 1985; 29 Suppl 5():49-56. PubMed ID: 3849425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin.
    Brenciaglia MI; Cipriani P; Ghezzi MC; Giordano A; Mancini C; Rivanera D; Filadoro F
    Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftizoxime (FK 749) in vitro antibacterial activity.
    Husson MO; Courcol R; Izard D; Leclerc H
    Infection; 1984; 12(1):40-5. PubMed ID: 6323320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
    Digranes A; Dibb WL; Benonisen E; Salveson A
    Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro studies with ceftazidime.
    Giamarellou H; Avlami A; Matsakas V; Kosmidis J; Daikos GK
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():73-7. PubMed ID: 19802972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.